Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2.
Jeremiah SS, Moin ASM, Butler AE.
Metabolism. 2024 Jul;156:155917. doi: 10.1016/j.metabol.2024.155917. Epub 2024 Apr 18.
Drug-Induced Hyperglycaemia and Diabetes.
Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C.
Drug Saf. 2015 Dec;38(12):1153-68. doi: 10.1007/s40264-015-0339-z.
COVID-19 and diabetes: A bidirectional relationship.
Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M.
Clin Investig Arterioscler. 2021 May-Jun;33(3):151-157. doi: 10.1016/j.arteri.2020.10.001. Epub 2020 Oct 28.
Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes.
Nobs SP, Kolodziejczyk AA, Adler L, Horesh N, Botscharnikow C, Herzog E, Mohapatra G, Hejndorf S, Hodgetts RJ, Spivak I, Schorr L, Fluhr L, Kviatcovsky D, Zacharia A, Njuki S, Barasch D, Stettner N, Dori-Bachash M, Harmelin A, Brandis A, Mehlman T, Erez A, He Y, Ferrini S, Puschhof J, Shapiro H, Kopf M, Moussaieff A, Abdeen SK, Elinav E.
Nature. 2023 Dec;624(7992):645-652. doi: 10.1038/s41586-023-06803-0. Epub 2023 Dec 13.
Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week.
Kittipibul V, Cox ZL, Chesdachai S, Fiuzat M, Lindenfeld J, Mentz RJ.
J Am Coll Cardiol. 2024 Apr 23;83(16):1568-1578. doi: 10.1016/j.jacc.2024.01.040.
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
Vallianou NG, Evangelopoulos A, Kounatidis D, Stratigou T, Christodoulatos GS, Karampela I, Dalamaga M.
Curr Diabetes Rev. 2021;17(6):e123120189797. doi: 10.2174/1573399817666210101110253.
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.
Debuysschere C, Nekoua MP, Alidjinou EK, Hober D.
Nat Rev Endocrinol. 2024 Oct;20(10):588-599. doi: 10.1038/s41574-024-01004-9. Epub 2024 Jun 18.
Coronavirus infection in patients with diabetes.
Torres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, Martínez-Alvarado MDR.
Arch Cardiol Mex. 2020;90(Supl):67-76. doi: 10.24875/ACM.M20000068.
COVID-19-Induced New-Onset Diabetes: Trends and Technologies.
Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP.
Diabetes. 2021 Dec;70(12):2733-2744. doi: 10.2337/dbi21-0029. Epub 2021 Oct 22.
Pathology of Diabetes-Induced Immune Dysfunction.
Alexander M, Cho E, Gliozheni E, Salem Y, Cheung J, Ichii H.
Int J Mol Sci. 2024 Jun 28;25(13):7105. doi: 10.3390/ijms25137105.
